| Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials WX Qi, LN Tang, AN He, Y Yao, Z Shen International journal of clinical oncology 19, 403-410, 2014 | 274 | 2014 |
| Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1) C Li, S Zhao, Y Zheng, Y Han, X Chen, Z Cheng, Y Wu, X Feng, W Qi, ... European journal of cancer 144, 232-241, 2021 | 197 | 2021 |
| Charged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysis WX Qi, S Fu, Q Zhang, XM Guo Radiotherapy and Oncology 114 (3), 289-295, 2015 | 134 | 2015 |
| Incidence and risk of hypertension with a novel multi‐targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta‐analysis WX Qi, AN He, Z Shen, Y Yao British journal of clinical pharmacology 76 (3), 348-357, 2013 | 121 | 2013 |
| Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis WX Qi, F Lin, Y Sun, LN Tang, AN He, Y Yao, Z Shen Cancer chemotherapy and pharmacology 71, 431-439, 2013 | 96 | 2013 |
| Risk of venous thromboembolic events associated with VEGFR‐TKIs: a systematic review and meta‐analysis WX Qi, DL Min, Z Shen, YJ Sun, F Lin, LN Tang, AN He, Y Yao International journal of cancer 132 (12), 2967-2974, 2013 | 90 | 2013 |
| Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta‐analysis of 36 … WX Qi, Z Shen, LN Tang, Y Yao British journal of clinical pharmacology 78 (4), 748-762, 2014 | 85 | 2014 |
| Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta‐analysis of clinical trials WX Qi, Z Shen, F Lin, Y Sun, D Min, LN Tang, AN He, Y Yao British Journal of Clinical Pharmacology 75 (4), 919-930, 2013 | 82 | 2013 |
| Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis WX Qi, YJ Sun, LN Tang, Z Shen, Y Yao Critical reviews in oncology/hematology 89 (3), 394-403, 2014 | 74 | 2014 |
| Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis WX Qi, Z Shen, LN Tang, Y Yao Critical reviews in oncology/hematology 92 (2), 71-82, 2014 | 72 | 2014 |
| Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups WX Qi, Z Shen, LN Tang, Y Yao European journal of clinical pharmacology 70, 893-906, 2014 | 71 | 2014 |
| Risk of interstitial lung disease associated with EGFR-TKIs in advanced non-small-cell lung cancer: a meta-analysis of 24 phase III clinical trials WX Qi, YJ Sun, Z Shen, Y Yao Journal of chemotherapy 27 (1), 40-51, 2015 | 70 | 2015 |
| CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study A He, W Qi, Y Huang, T Feng, J Chen, Y Sun, Z Shen, Y Yao Experimental and therapeutic medicine 4 (3), 435-441, 2012 | 70 | 2012 |
| Risk of hypertension in cancer patients treated with aflibercept: a systematic review and meta-analysis WX Qi, Z Shen, LN Tang, Y Yao Clinical drug investigation 34, 231-240, 2014 | 64 | 2014 |
| Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab WX Qi, Y Xiang, S Zhao, J Chen Cancer Immunology, Immunotherapy, 1-8, 2021 | 59 | 2021 |
| Comparison of the efficacy and safety of EFGR tyrosine kinase inhibitor monotherapy with standard second-line chemotherapy in previously treated advanced non-small-cell lung … WX Qi, Z Shen, F Lin, YJ Sun, DL Min, LN Tang, AN He, Y Yao Asian Pacific journal of cancer prevention 13 (10), 5177-5182, 2012 | 57 | 2012 |
| Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials WX Qi, Z Shen, F Lin, Y Sun, D Min, LN Tang, AN He, Y Yao Current medical research and opinion 29 (2), 117-125, 2013 | 55 | 2013 |
| Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systematic review and pooled analysis of randomized controlled studies WX Qi, F Lin, AN He, LN Tang, Z Shen, Y Yao Current medical research and opinion 29 (9), 1067-1073, 2013 | 50 | 2013 |
| The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis YJ Huang, WX Qi, AN He, YJ Sun, Z Shen, Y Yao Japanese journal of clinical oncology 43 (10), 988-995, 2013 | 49 | 2013 |
| Incidence and risk of hemorrhagic events with vascular endothelial growth factor receptor tyrosine-kinase inhibitors: an up-to-date meta-analysis of 27 randomized controlled trials WX Qi, LN Tang, YJ Sun, AN He, F Lin, Z Shen, Y Yao Annals of Oncology 24 (12), 2943-2952, 2013 | 48 | 2013 |
Hongliang LiM.D.,Ph.D.在 ouhsc.edu 的电子邮件经过验证
